In a paper published in Nature Scientific Reports last week, researchers from the Human Protein Atlas describe a method for stratification of responders towards the drug eculizumab that allows for precision medicine and should be applicable to several other diseases and therapeutics.
The term precision medicine describes the idea of providing effective treatment based on a patient´s molecular make up. Recent advances in molecular diagnostic tools and handling of large data sets allow for the stratification of patients based on e.g. genetic or protein information and make it possible to provide tailored treatment for these sub-groups...Read more
January 8, 2018
Prof. Sophia Hober will present the latest advances regarding engineering of protein A, for Ca-mediated purification of antibodies. Her talk is scheduled on January 9, during one of the largest annual events focusing on protein science, the PepTalk conference.
January 8, 2018 - January 12, 2018
Development of the Human Protein Atlas, protein production pipeline will be highlighted in the upcoming PepTalk conference in a talk given by PhD Hanna Tegel.